Dr. Wray is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-590-1000Fax+1 215-590-3992
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2009 - 2012- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2007 - 2009
UPMC Medical EducationInternship, Pediatrics, 2006 - 2007
Lewis Katz School of Medicine at Temple UniversityClass of 2006
Certifications & Licensure
PA State Medical License 2008 - 2026
DE State Medical License 2013 - 2019
NJ State Medical License 2014 - 2019
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma Start of enrollment: 2023 May 23
Publications & Presentations
PubMed
- Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy.Barbara D Friedes, Amanda M DiNofia, Emma Iannone, Yimei Li, Susan R Rheingold
Blood Advances. 2025-01-28 - 2 citationsQuadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents.Caroline Diorio, Laura Hernandez-Miyares, Diego A Espinoza, Brenda L Banwell, Amit Bar-Or
Blood. 2024-09-26 - 3 citationsReinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia.Regina M Myers, Kaitlin Devine, Yimei Li, Sophie Lawrence, Allison Barz Leahy
Blood Advances. 2024-05-14
Abstracts/Posters
- Cytogenetic Characteristics and Outcomes of Patients Receiving CTL019 CAR T Cell TherapyLisa Wray, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Trends in Inpatient and Intensive Care Resource Utilization after Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia from 2012-2019Lisa Wray, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
